Assignee
TEVA PHARMACEUTICALS INT GMBH
CH·50 granted patents·100 pending applications·163 citations·filing 2000–2025
Top patents by PatentIndex Score
150 records- 0197US9884907B2Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptideTEVA PHARMACEUTICALS INT GMBH·Filed 2017·Granted Feb 6, 2018·15 cites·18 claims
- 0297US9884908B2Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptideTEVA PHARMACEUTICALS INT GMBH·Filed 2017·Granted Feb 6, 2018·15 cites·18 claims
- 0396US9890210B2Antagonist antibodies directed against calcitonin gene-related peptideTEVA PHARMACEUTICALS INT GMBH·Filed 2017·Granted Feb 13, 2018·11 cites·15 claims
- 0496US9890211B2Antagonist antibodies directed against calcitonin gene-related peptideTEVA PHARMACEUTICALS INT GMBH·Filed 2017·Granted Feb 13, 2018·11 cites·15 claims
- 0593US11028160B2Treating refractory migraineTEVA PHARMACEUTICALS INT GMBH·Filed 2020·Granted Jun 8, 2021·4 cites·30 claims
- 0693US10329343B2Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptideTEVA PHARMACEUTICALS INT GMBH·Filed 2018·Granted Jun 25, 2019·5 cites·24 claims
- 0790US11028161B2Treating refractory migraineTEVA PHARMACEUTICALS INT GMBH·Filed 2020·Granted Jun 8, 2021·2 cites·30 claims
- 0890US2024158481A1Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using SameTEVA PHARMACEUTICALS INT GMBH·Filed 2023·Application pending·0 cites
- 0989US11773083B2Solid state forms of Belumosudil and Belumosudil saltsTEVA PHARMACEUTICALS INT GMBH·Filed 2022·Granted Oct 3, 2023·2 cites·10 claims
- 1089US9814706B2Hydrobromide salt of pridopidineTEVA PHARMACEUTICALS INT GMBH·Filed 2015·Granted Nov 14, 2017·13 cites·7 claims
- 1189USRE46117EModulators of dopamine neurotransmissionTEVA PHARMACEUTICALS INT GMBH·Filed 2000·Granted Aug 23, 2016·28 cites·52 claims
- 1288US11053261B2Solid state forms of ixazomib citrateTEVA PHARMACEUTICALS INT GMBH·Filed 2020·Granted Jul 6, 2021·2 cites·12 claims
- 1388US10519224B2Treating headache comprising administering an antibody to calcitonin gene-related peptideTEVA PHARMACEUTICALS INT GMBH·Filed 2018·Granted Dec 31, 2019·7 cites·23 claims
- 1488US10392434B2Treating refractory migraineTEVA PHARMACEUTICALS INT GMBH·Filed 2017·Granted Aug 27, 2019·4 cites·13 claims
- 1588US9896502B2Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameTEVA PHARMACEUTICALS INT GMBH·Filed 2015·Granted Feb 20, 2018·8 cites·20 claims
- 1687US2025263474A1Treating refractory migraineTEVA PHARMACEUTICALS INT GMBH·Filed 2024·Application pending·0 cites
- 1784US10604537B2Solid state forms of ixazomib citrateTEVA PHARMACEUTICALS INT GMBH·Filed 2017·Granted Mar 31, 2020·2 cites·16 claims
- 1884US10556945B2Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameTEVA PHARMACEUTICALS INT GMBH·Filed 2015·Granted Feb 11, 2020·3 cites·19 claims
- 1983US11306104B2Solid state forms of RelugolixTEVA PHARMACEUTICALS INT GMBH·Filed 2019·Granted Apr 19, 2022·5 cites·12 claims
- 2083US10646443B2Sustained release olanzapine formulationsTEVA PHARMACEUTICALS INT GMBH·Filed 2018·Granted May 12, 2020·2 cites·58 claims
- 2182US12139528B2Treating refractory migraineTEVA PHARMACEUTICALS INT GMBH·Filed 2023·Granted Nov 12, 2024·0 cites·19 claims
- 2281US10172682B2Medical device packagingTEVA PHARMACEUTICALS INT GMBH·Filed 2017·Granted Jan 8, 2019·14 cites·13 claims
- 2380US12157729B2Solid state forms of Belumosudil and Belumosudil saltsTEVA PHARMACEUTICALS INT GMBH·Filed 2023·Granted Dec 3, 2024·0 cites·15 claims
- 2480US11555064B2Treating headache comprising administering an antibody to calcitonin gene-related peptideTEVA PHARMACEUTICALS INT GMBH·Filed 2019·Granted Jan 17, 2023·1 cites·43 claims
- 2579US10323085B2Methods of treating fibromyalgiaTEVA PHARMACEUTICALS INT GMBH·Filed 2018·Granted Jun 18, 2019·1 cites·18 claims
- 2679US2025066333A1Solid state forms of belumosudil and belumosudil saltsTEVA PHARMACEUTICALS INT GMBH·Filed 2024·Application pending·0 cites
- 2779US2025066334A1Solid state forms of belumosudil and belumosudil saltsTEVA PHARMACEUTICALS INT GMBH·Filed 2024·Application pending·0 cites
- 2879US2022056114A1Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using SameTEVA PHARMACEUTICALS INT GMBH·Filed 2021·Application pending·0 cites
- 2978US11932627B2Solid state forms of Belumosudil and Belumosudil saltsTEVA PHARMACEUTICALS INT GMBH·Filed 2023·Granted Mar 19, 2024·0 cites·16 claims
- 3078US2020247878A1Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using SameTEVA PHARMACEUTICALS INT GMBH·Filed 2019·Application pending·0 cites
- 3178US2024238307A1Sustained release olanzapine formulationsTEVA PHARMACEUTICALS INT GMBH·Filed 2024·Application pending·0 cites
- 3277US11541177B2Injection spring for aged prefilled syringe and auto injectorTEVA PHARMACEUTICALS INT GMBH·Filed 2019·Granted Jan 3, 2023·2 cites·19 claims
- 3377US10597448B2Methods for treating visceral pain associated with interstitial cystitis by administering antagonist antibodies directed against calcitonin gene-related peptideTEVA PHARMACEUTICALS INT GMBH·Filed 2018·Granted Mar 24, 2020·1 cites·6 claims
- 3477US2025065049A1Injection spring for aged prefilled syringe and auto injectorTEVA PHARMACEUTICALS INT GMBH·Filed 2024·Application pending·0 cites
- 3576US2024287072A1Solid state forms of lumateperone salts and processes for preparation of lumateperone and salts thereofTEVA PHARMACEUTICALS INT GMBH·Filed 2024·Application pending·0 cites
- 3675US2025073166A1Sustained Release Olanzapine FormulationsTEVA PHARMACEUTICALS INT GMBH·Filed 2024·Application pending·0 cites
- 3774US10899826B1Pharmaceutical compositions for an anti-CGRP antagonist antibodyTEVA PHARMACEUTICALS INT GMBH·Filed 2019·Granted Jan 26, 2021·1 cites·52 claims
- 3874US2021317196A1Methods of Treating Chronic PainTEVA PHARMACEUTICALS INT GMBH·Filed 2020·Application pending·0 cites
- 3974US2022017608A1Methods of Treating Inflammatory PainTEVA PHARMACEUTICALS INT GMBH·Filed 2021·Application pending·0 cites
- 4073US2022098287A1Treating refractory migraineTEVA PHARMACEUTICALS INT GMBH·Filed 2021·Application pending·0 cites
- 4172US11981624B2Crystalline polymorphs of Rigosertib SodiumTEVA PHARMACEUTICALS INT GMBH·Filed 2019·Granted May 14, 2024·0 cites·21 claims
- 4272US11673860B2Crystalline siponimod fumaric acid and polymorphs thereofTEVA PHARMACEUTICALS INT GMBH·Filed 2019·Granted Jun 13, 2023·1 cites·20 claims
- 4372US2023382914A1Solid state forms of lumateperone ditosylate saltTEVA PHARMACEUTICALS INT GMBH·Filed 2023·Application pending·0 cites
- 4472US2019092841A1Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using SameTEVA PHARMACEUTICALS INT GMBH·Filed 2018·Application pending·0 cites
- 4572US2022323458A1Sustained release olanzapine formulationsTEVA PHARMACEUTICALS INT GMBH·Filed 2022·Application pending·0 cites
- 4672US2023235032A1Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using SameTEVA PHARMACEUTICALS INT GMBH·Filed 2022·Application pending·0 cites
- 4772US2025236643A1Solid state forms of voclosporinTEVA PHARMACEUTICALS INT GMBH·Filed 2025·Application pending·0 cites
- 4870US11760757B2Solid state forms of lumateperone ditosylate saltTEVA PHARMACEUTICALS INT GMBH·Filed 2022·Granted Sep 19, 2023·0 cites·20 claims
- 4970US2025263380A1Solid state forms of mitapivat and process for preparation thereofTEVA PHARMACEUTICALS INT GMBH·Filed 2025·Application pending·0 cites
- 5070US2020148752A1Methods of Treating Inflammatory PainTEVA PHARMACEUTICALS INT GMBH·Filed 2019·Application pending·0 cites
Showing the top 50 of 150 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when TEVA PHARMACEUTICALS INT GMBH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →